UC San Diego researchers report successfully removing the nucleus from a type of ubiquitous cell, then using the genetically engineered cell as a unique cargo-carrier to deliver therapeutics precisely to diseased tissues.Researchers at University of California San Diego School of Medicine and Moores
News
Jacobs Medical Center Marks Fifth Anniversary, Achievements and Milestones
Jacobs Medical Center at UC San Diego Health marks its fifth anniversary and celebrates achievements and milestones while providing the most advanced medical and surgical care in the region.
[…]
News
UC San Diego Partners with 5 Leading Diagnostics Manufacturers to Boost COVID-19 Testing
Partnering with five diagnostics manufacturers, UC San Diego is significantly ramping up testing for COVID-19, projecting capacity to complete up to 1,500 tests daily within two to three weeks.
[…]
